| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |